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Abstract
Background: In order to establish a consistent method for brachial artery reactivity assessment,
we analyzed commonly used approaches to the test and their effects on the magnitude and time-
course of flow mediated dilation (FMD), and on test variability and repeatability. As a popular and
noninvasive assessment of endothelial function, several different approaches have been employed
to measure brachial artery reactivity with B-mode ultrasound. Despite some efforts, there remains
a lack of defined normal values and large variability in measurement technique.
Methods:  Twenty-six healthy volunteers underwent repeated brachial artery diameter
measurements by B-mode ultrasound. Following baseline diameter recordings we assessed
endothelium-dependent flow mediated dilation by inflating a blood pressure cuff either on the
upper arm (proximal) or on the forearm (distal).
Results: Thirty-seven measures were performed using proximal occlusion and 25 with distal
occlusion. Following proximal occlusion relative to distal occlusion, FMD was larger (16.2 ± 1.2%
vs. 7.3 ± 0.9%, p < 0.0001) and elongated (107.2 s vs. 67.8 s, p = 0.0001). Measurement of the test
repeatability showed that differences between the repeated measures were greater on average
when the measurements were done using the proximal method as compared to the distal method
(2.4%; 95% CI 0.5–4.3; p = 0.013).
Conclusion: These findings suggest that forearm compression holds statistical advantages over
upper arm compression. Added to documented physiological and practical reasons, we propose
that future studies should use forearm compression in the assessment of endothelial function.
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Background
Impaired endothelial function is recognized as an early
and modulating process in the pathophysiology of
atherosclerotic cardiovascular disease[1]. Endothelial
function is often quantified by flow-mediated dilation
(FMD), which represents the endothelium-dependent
relaxation of a conduit artery-typically the brachial artery
– due to an increased blood flow. Brachial artery reactivity
is a frequently used non-invasive ultrasonographic assess-
ment of FMD that indicates endothelium-dependent
response to shear stress[2]. This measure is a marker for
increased cardiovascular risk[3], and correlates with
impaired endothelium-dependent relaxation in the coro-
nary arteries[4]. Due to lack of a standardized method to
measure brachial artery reactivity[5,6], we sought to eval-
uate the impact of different circulatory occlusion sites
(upper arm and forearm occlusion locations) and timing
of measurements, in order to establish a consistent
method for brachial artery reactivity assessment in a
future study of environmental health effects. We assessed
the magnitude and temporal characteristics of the
response as well as for sources and levels of variability and
repeatability of measurements. This study leads to further




Twenty-six volunteers participated in the study. Partici-
pants were age 18–49, healthy, normotensive, nonsmok-
ers. The study was approved by the University of
Washington Human Subjects Review Committee; subjects
provided informed consent for all procedures.
Study protocols
In the first 19 participants, FMD was measured twice on
two separate days, at least two weeks apart. In the remain-
ing seven participants, FMD was measured on two sepa-
rate days, on two occasions on each day separated by one
hour for all individuals.
All measurements of brachial artery diameter and FMD
were performed in the morning, in a quiet and dark room
and at controlled ambient temperatures between 20°C
and 26°C. The electrocardiogram (ECG) was continu-
ously monitored. Female participants were examined dur-
ing the follicular phase of their menstrual cycle. Studies
were conducted after an overnight fast of at least 10 hours
(water was permitted), with the subjects supine and after
10 minutes of rest. The subject's right arm was comforta-
bly immobilized in the extending position, allowing for
ultrasound scanning of the brachial artery 5–10 cm above
the antecubital fossa.
In each examination, recording of vessel images were fol-
lowed by inflation of a cuff to suprasystolic pressure (40
to 50 mmHg above systolic pressure) for 5 minutes as sug-
gested by findings in Corretti et al[7]. Then the brachial
artery diameter was imaged and recorded for 3 minutes.
The first 19 participants were randomly assigned to cuff
inflation either on the forearm, or upper arm. In the
remaining seven participants the cuff was inflated on the
forearm on the first day and upper arm on the second day.
Due to the location of the occluding cuff, the transducer
was positioned in a slightly lower position in the studies
conducted with proximal occlusion compared to those
with distal occlusions.
Image acquisition
The brachial artery was scanned in the longitudinal sec-
tion using an HDI 5000 Ultrasound Instrument (Philips
Medical Systems, Bothell, WA) with a 5–12 MHz linear
array transducer. One experienced sonographer collected
all images. Images were digitized from the video output of
the ultrasound machine using a frame grabber under con-
trol of custom software on a personal computer. Image
acquisition was gated with an ECG signal so that images
were captured at end diastole in each cardiac cycle.
Image analysis
Brachial artery diameter was assessed by a single trained
operator using an automated, beat-by-beat image process-
ing software package (Vascular Tools 4.6, Medical Imag-
ing Applications, USA). This analysis technique was
previously introduced [8] and independently vali-
dated[9,10]. Briefly, the operator defined a vascular
region of interest, which was then applied automatically
to identify the media-to-media diameters in each frame
over time. We used two measures of quality control: we
excluded from the analysis frames with a detected vessel
border smaller than 70% of the width of the region of
interest (confidence index > 70%) and, for post-cuff defla-
tion sessions only, frames with diameters that differ by
more than 1 standard deviation from a polynomial fit.
Custom software developed in the MATLAB programming
environment (The MathWorks, Natick, MA) was used to
extract measurements from the time series of diameter
measurements. The capture time for each image was
decoded by optical character recognition of the time of
day displayed on each image frame. The sequence of
diameter measurements was then interpolated to equally-
spaced time samples at 1-second intervals. This interpo-
lated sequence was smoothed by a 9-point median filter
followed by a 9-point Gaussian-weighted moving average.
The following parameters were measured from the result-
ing time sequence of brachial artery diameter (Figure 1):
mean baseline brachial artery diameter (DBL) measured in
millimeters; peak FMD measured in percentage and calcu-BMC Cardiovascular Disorders 2007, 7:11 http://www.biomedcentral.com/1471-2261/7/11
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lated as [(Dmax-DBL)/DBL] × 100; time-to-peak FMD meas-
ured in seconds; diameter change at the end of the post-
cuff deflation period (Dend) measured in percentage and
calculated from the average diameter of the last 10 sec-
onds of the post-cuff release period relative to DBL.
Statistical analysis
Descriptive data are presented as mean ± standard error
(SE) unless specified otherwise. Dmax, time-to-peak FMD,
and Dend were compared between cuff positions using
ANOVA with correction for gender and the level to which
the blood pressure cuff was inflated (i.e. 40 or 50 mmHg
above systolic blood pressure).
Variability and repeatability of the test were measured and
compared between the two cuff positions. Assessment of
variability included: calculation of the coefficient of vari-
ation (CV) of the baseline diameters from accepted frames
to determine the within-session variability; mean CV from
2 or more baseline measurements for each of the first 19
participants as a day-to-day variability. Both descriptors
were calculated for the two cuff locations and then com-
pared by independent t test.
Repeatability for FMD analysis for each cuff location was
calculated using intraclass correlation coefficient (ICC) in
a two-way mixed effects model, and Bland & Altman plots
with calculation of the repeatability coefficient[11]. SPSS
12.0 (Chicago, Illinois) statistical software and Microsoft
Excel were used.
In addition, a linear model was run to assess whether the
absolute values of the difference in FMD between test and
retest were different using the proximal versus the distal
circulatory occlusion. To account for the correlation
between distal and proximal comparisons done on same
subjects, a generalized estimating equations (GEE)
approach was used, assuming an exchangeable correla-
tion structure. S-plus 7.0 (Insightful Corp. 2005) statisti-
cal software was used. Results from all tests were
considered statistically significant if p <0.05.
Results
A total of 62 ultrasound examinations of the brachial
artery followed by assessment of endothelium-dependent
flow mediated vasodilation were analyzed in this paper,
37 with upper arm cuff location, and 25 with forearm cuff
location. Participants' mean age was 28.4 (range, 20–42
yr). More male (N = 16) than female (N = 10) participated
in the study.
Overall, mean baseline brachial artery diameter from 37
sessions with upper arm occlusion was smaller (3.8 ± 0.1)
than that from 25 sessions acquired with forearm occlu-
sion (4.2 ± 0.2) (p = 0.058). This difference between base-
line diameters appears to be related to the slightly
different location of the ultrasound transducer on the par-
ticipants' arm. In fact, similar results were obtained after
limiting analysis to those participants that were evaluated
with both proximal and distal occlusion (data not
shown). Mean number of frames obtained for baseline
Representative flow-mediated response of brachial artery (forearm occlusion) Figure 1
Representative flow-mediated response of brachial artery (forearm occlusion). Measurements are used to charac-
terize the brachial artery response: 1) baseline diameter (DBL), 2) maximum diameter after cuff release (Dmax), 3) diameter 3 
minutes after cuff release, 4) time of maximum diameter after cuff release.BMC Cardiovascular Disorders 2007, 7:11 http://www.biomedcentral.com/1471-2261/7/11
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diameter assessment was similar for both proximal and
distal cuff locations (81.7 vs. 81.5 respectively).
Flow Mediated Dilation
Pooling all the brachial artery reactivity tests together, we
found that peak FMD using the upper arm (N = 37) was
greater than that for the forearm (N = 25) (16.2 ± 1.2% vs.
7.3 ± 0.9, p < 0.0001). The gender and the pressure to
which the cuff was inflated did not alter these results (data
not shown).
The time course of the average dilation of the brachial
artery from cuff release is shown in figure 2. Upper arm
cuff placement resulted in a slow increase, with a peak
diameter of 15.9 ± 1.2% after 109 seconds; forearm cuff
placement generated a smaller peak (6.6 ± 0.8%) after
only 67 seconds post-cuff-deflation. For the entire record-
ing time (180 seconds) brachial artery diameter values
were greater than baseline for both cuff locations.
On average, the time-to-peak FMD was 107.2 ± 6 seconds
for upper arm cuff inflation and 67.8 ± 8.9 seconds for
forearm cuff inflation (p = 0.0001). After peak dilation,
the artery diameter decrements were slower with proximal
occlusion than distal occlusion. At the end of the three-
minute image capture period after cuff release, Dend was
11.3 ± 1.2% with proximal cuff occlusion, and 3.3 ± 0.8%
with the distal cuff occlusion (p = 0.0001).
The peak FMD responses from all examinations (N = 62)
grouped in a cumulative frequency representation shows
that utilizing the proximal arm test, ~35% of subjects had
not reached their maximal FMD response by the average
time (107.2 seconds) (Figure 3a). For the forearm test,
~30% of individuals had not reached their maximal
response by the average time (67.8 seconds) (Figure 3b).
For both the proximal and distal tests, all subjects reached
their maximal response by 180 seconds.
Variability and Repeatability
For the 62 studies for which ~80 baseline frames were
taken in a single session, the within-session diameter var-
iability was small (CV = 0.85 ± 0.04%); there was no sta-
tistically significant difference between the upper arm cuff
Time course of brachial artery dilation following reactive hyperemia Figure 2
Time course of brachial artery dilation following reactive hyperemia. Time course in 10-second intervals of brachial 
artery FMD expressed as percent difference from baseline diameter after upper arm cuff inflation (upper curve) and forearm 
cuff inflation (lower curve). Each point in the graphs represents an average of all data available in that time-point; the error bars 
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location (CV= 0.85 ± 0.05%) and the more distal location
(CV= 0.84 ± 0.06%). Day-to-day variability of baseline
diameter was also small for both the distal cuff placement
(CV = 3.4 ± 1.3%) and the proximal one (CV = 5.1 ±
1.7%), with no statistically significant difference between
them.
The repeatability of the test for peak FMD using Bland-Alt-
man plots is presented in figure 4. The coefficient of
repeatability thus calculated is high for both proximal cuff
location (CR = 14.11%) and the distal cuff location (CR =
10.11%).
The intraclass correlation coefficient (ICC) between peak-
FMD of two repeated measures was 0.6 (95%CI -0.2:0.8)
for the upper arm occlusions, and 0.6 (95%CI -0.7:0.9)
for the forearm occlusion. Using the GEE approach we
found that the magnitude of the differences between the
repeated measures were on average 2.4% (95% CI 0.5–
4.3; p = 0.013) greater when the measurements were done
using the proximal method as compared to the distal
method.
Discussion
In this study we evaluated statistical reasons to support
application of specific conditions to FMD testing on the
brachial artery. While assessment of FMD of the brachial
artery either with proximal (upper arm), or distal (fore-
arm) occlusion has been found to be correlated with cor-
onary endothelial function[12,13], we evaluated whether
other test characteristics may provide a basis for selecting
one approach over the other.
We have confirmed the well established finding that the
maximal FMD is greater and delayed with upper arm
occlusion[6,14-20]. We showed a significantly greater and
delayed FMD following proximal occlusion (16.2% and
107.2 seconds, respectively) compared to distal occlusion
(7.3% and 67.8 seconds). The difference in the magnitude
of FMD between occlusion sites (8.9%) is greater than the
difference reported in a recent meta-analysis (2.4%)[18].
This discrepancy may be due to three major reasons. First,
the measures were made in populations with different
baseline endothelial function. Second, differences in
baseline diameters in each of the two occlusion sites, may
Cumulative frequency of individual peak dilations after cuff deflation Figure 3
Cumulative frequency of individual peak dilations after cuff deflation. (A) Upper arm cuff inflation; (B) Forearm cuff 
inflation. Dashed lines represent the percentage of individuals with maximal response at the average time-to-peak FMD for 
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have affected the shear stress, the stimulus for endothe-
lium-dependent dilation[21]. In this study, shear stress
was not analyzed. Finally, our use of an automated
method of analysis with all available frames. Others stud-
ies that demonstrated greater FMD in response to proxi-
mal occlusion rather than distal occlusion [14-20]
captured brachial artery images continuously, but then
examined frames from specific time-points to define the
artery's diameter and the frequency of these intervals was
not consistent between studies.
The time to maximal FMD may vary not only by occlusion
site, but also by the method used to detect the diameter
from captured frames. For example, adhering to the rec-
ommended time interval to maximal FMD at 60 seconds
after the release of the occlusive cuff [22] would have
resulted in missing the true peak-FMD of 40% of the
measurements we obtained with forearm occlusion (fig-
ure 3b), and about 95% of the cases of upper arm occlu-
sion (figure 3a). Random measurement errors and
underestimation of the actual FMD are less likely when
examination of brachial artery dilation is done continu-
ously over the entire course of the session and analyzed
from all available images with automated computer based
edge detection.
The assessment of FMD of the brachial artery is a func-
tional bioassay for in vivo endothelial function in humans.
It has been stated that the primary mechanism responsi-
ble for vessel dilation with forearm occlusion is endothe-
lial release of nitric oxide(NO)[23]. Doshi et al.
demonstrated that most of the dilatory response to proxi-
mal occlusion is NO-independent[14]. Additional mech-
anisms, such as direct effect of hypoxia on the smooth
muscle, altered myogenic response, or altered release of
other mediators involved in vessel reactivity, may be
involved in the dilation of the brachial artery following
upper arm occlusion. NO-mediated vasodilation occurs
~60–80 seconds following reperfusion[24,25]. Therefore,
in the absence of a pharmacologic intervention, the
increased time to maximal FMD and the prolonged dila-
tory response (Dend 11.3% vs. 3.3% p <0.0001) for proxi-
mal occlusion relative to distal occlusion may reflect other
underlying mechanisms. NO is not the only mediator
involved in FMD following proximal and distal occlu-
sions; other endothelium-derived factors are probably
involved differently with the two occlusion locations. It is
essential to conduct validation studies in order to under-
stand the role of different components of endothelial
function in one approach or the other of the test.
Many studies have assessed the variability of the brachial
artery diameter measurements, both at baseline and dur-
ing the dilatory response. While the baseline diameter was
shown to have relatively small variability (CV range 1–
13%), the maximal FMD was associated with a much
Reproducibility of Flow-Mediated Dilation (FMD) using Bland-Altman plots Figure 4
Reproducibility of Flow-Mediated Dilation (FMD) using Bland-Altman plots. (A) Upper arm cuff inflation; (B) Fore-
arm cuff inflation. The x-axis illustrates the individual average values of peak-FMD. The y-axis shows the differences between 
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greater range of variability (CV range 1–84%)[26]. Vari-
ous factors may contribute to the variability of brachial
artery diameter, and these can be largely divided into tech-
nical and physiological factors[27]. Ultrasound of the bra-
chial artery is technically challenging, and measurement
errors – even in magnitude of fraction of millimeters –
especially when added to effect of intrinsic factors affect-
ing FMD, may affect the accuracy of the test. Therefore, it
is essential to apply a rigorous methodology to the test. In
doing so, we utilized a single ultrasound machine, all
studies were performed by one technician, and all images
were read by one off-line reader. We found relatively low
within-session variability and day-to-day variability of
baseline diameter with no difference between proximal
and distal placements. Similar day-to-day variability was
found by Uehata et al[28]. Greater variability of peak
FMD is shown by the relatively high fraction of partici-
pants (more than a third, in both occlusion sites) that did
not reach their maximal FMD by the average time-to-peak
FMD (figure 3). The small impact of technical factors on
baseline brachial artery diameter variability may indicate
that physiological factors contribute most of peak FMD
variability as suggested previously[29].
In this study we did not quantify the shear stress. It has
been observed that the shear stress computed as area
under the curve, is the major contributor to the magnitude
of FMD[30]. Therefore it is plausible that variability in
shear stress may affect variability and repeatability of
FMD, and understanding this interplay requires addi-
tional study.
We also assessed the repeatability of FMD, an important
quality of this outcome as a potential tool in clinical stud-
ies where repeated measures are needed, and as a poten-
tial indicator for the risk of future coronary disease.
Previous studies have shown inconsistent results of bra-
chial artery FMD repeatability. Malik at al[31] reported
poor repeatability of FMD with an intraclass correlation
coefficient of 0.1. In contrast, Welsch et al[32] reported an
intraclass correlation coefficient of 0.92 comparing day-
to-day FMD. We demonstrated a reasonable repeatability
of FMD measurements. Repeatability of FMD was better
for the distal cuff location as shown by the smaller coeffi-
cient of repeatability (CR = 10.1% vs. 14.1%) and the
greater difference on average of two repeated measure-
ments with upper arm cuff placement (2.4%). Even with
accurate methodology, our repeatability was only modest;
suggesting that some degree of measurement error is inev-
itable in any setting. However, it is reasonable to assume
that studies that use more than one sonographer or are
performed in more than one center may be subject to a
greater degree of measurement error than observed in this
study. Hence, such studies must be extremely well coordi-
nated, using highly trained technical staff, and probably
employ a larger sample size than single site studies. The
use of duplicate measurements may be important in
reducing measurement error, as evidence show that repet-
itive reactive hyperemia does not effect FMD measure-
ments [33], though the minimum time between
measurements has not been clearly identified.
Conclusion
For brachial artery reactivity to be a widespread clinical
and research tool, the flow mediated dilation measure-
ment of the brachial artery should be standardized, and
centers should adhere to a more consistent analysis proto-
col. Our data suggest that the choice of the location of cuff
inflation may have statistical implications that favor the
forearm approach. There are established physiological
reasons that support employing one approach over the
other. While FMD following distal occlusion is mainly
NO dependent, other – not as well elucidated – factors are
involved in the dilatory response to upper arm occlusion.
In future studies we will study the effects of an environ-
mental insult on FMD of the brachial artery, while meas-
uring different components of endothelial function. In
the absence of a well characterized mechanism involved
in the flow mediated dilation of the brachial artery with
upper arm occlusion, based on our results, we suggest that
the forearm occlusion be used. The cuff should be inflated
five cm distal to the elbow for five minutes, then, in the
post-hyperemic phase of the test the brachial artery
should be scanned continuously. Post-cuff deflation
examination should be continued for three minutes in
healthy adults, whereas, in adults at risk for CAD or with
known disease, it is likely necessary to capture the artery's
images for longer periods. Last, we suggest also that the
images be analyzed with an automated computer-based
edge detection algorithm. This will allow for a time series
analysis of all brachial artery diameters and identification
of the true maximal FMD. More studies performed with
standardized method are needed to confirm our findings
and allow for potential future use of the test for clinical
purposes.
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